[Research progress on biologics and therapeutic drug monitoring in pediatric inflammatory bowel disease]
{{output}}
The incidence of pediatric inflammatory bowel disease (IBD) is rising, with an especially high proportion of early-onset cases in Asia. Conventional treatments such as glucocorticoids and immunosuppressants have limited efficacy and notable adverse effects, wh... ...
